Author
Listed:
- Zeyu Liang
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University)
- Qiyue Wang
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University)
- Hongwei Liao
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University)
- Meng Zhao
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University
Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University)
- Jiyoung Lee
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University)
- Chuang Yang
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University
Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University)
- Fangyuan Li
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University
Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University)
- Daishun Ling
(Institute of Pharmaceutics and College of Pharmaceutical Sciences, Zhejiang University
Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University
School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, National Center for Translational Medicine, Shanghai Jiao Tong University)
Abstract
Histopathological level imaging in a non-invasive manner is important for clinical diagnosis, which has been a tremendous challenge for current imaging modalities. Recent development of ultra-high-field (UHF) magnetic resonance imaging (MRI) represents a large step toward this goal. Nevertheless, there is a lack of proper contrast agents that can provide superior imaging sensitivity at UHF for disease detection, because conventional contrast agents generally induce T2 decaying effects that are too strong and thus limit the imaging performance. Herein, by rationally engineering the size, spin alignment, and magnetic moment of the nanoparticles, we develop an UHF MRI-tailored ultra-sensitive antiferromagnetic nanoparticle probe (AFNP), which possesses exceptionally small magnetisation to minimize T2 decaying effect. Under the applied magnetic field of 9 T with mice dedicated hardware, the nanoprobe exhibits the ultralow r2/r1 value (~1.93), enabling the sensitive detection of microscopic primary tumours (
Suggested Citation
Zeyu Liang & Qiyue Wang & Hongwei Liao & Meng Zhao & Jiyoung Lee & Chuang Yang & Fangyuan Li & Daishun Ling, 2021.
"Artificially engineered antiferromagnetic nanoprobes for ultra-sensitive histopathological level magnetic resonance imaging,"
Nature Communications, Nature, vol. 12(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24055-2
DOI: 10.1038/s41467-021-24055-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24055-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.